Steve and I spent a busy 4 days at the AADE, learning the value of education and tighter glucose control for the patients. We would like to thank the nearly 1000 AADE members that stopped by our booth and tried the slow carb muffins. While I was touring the exhibit hall …

Foot Exam Flow Sheet This is a great tool to use as a reminder for you to do a foot exam each time you see a patient.  It can be used to motivate your patient to better self-care as they can see the progression of their neuropathy. Foot Exam Flow Sheet

Sharon Vacha, Dr of Pharmacy Candidate, 2010 Dave Joffe, Editor Tethys Bioscience has developed a predictive blood test to evaluate a patient’s 5 year risk of developing Type 2 diabetes. This company has articles in two publications, Diabetes Care and The Journal of Diabetes Science and Technology, outlining how they …

Pitavastatin (Livalo, Kowa Pharmaceuticals), a HMG-CoA reductase inhibitor, was approved as a primary treatment for hypercholesterolemia and combined dyslipidemia. This new medication has a unique cyclopropyl group on its base structure, giving it the potential for greater LDL clearance and the reduction of plasma cholesterol. The manufacturer also said that …

For patients with good A1c levels, continuous glucose monitoring will be beneficial, according to a new report. 

A new study found that people with low blood levels of a protein that regulates sex hormones are at higher risk of diabetes, and genetics may play a role in determining both the levels and the risk.  

Metformin, one of the most widely used diabetes drugs, may offer patients the added benefit of lowering their odds for pancreatic cancer by 62%, a new study shows. 

The analysis of this large Atherosclerosis Risk in Communities (ARIC) study found that over a 12 year period, all individuals who increased their exercise by about 180 metabolic units per week (equivalent to an additional hour of mild or 30 minutes of moderate activity per week) displayed decreased levels of …

In patients with Type 1 diabetes, the presence and severity of chronic kidney disease predicts all-cause mortality, according to a new report. 

By activating one gene, researchers can reprogram cells to produce insulin, according to a study in the journal Cell.